Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary

Covid-19 related prescribing guidance

Checked: not set yet by Next Review: not set yet

General Advice on Medicines and Covid-19 Virus

Please click here for PrescQIPP's summary of guidance for COVID-19 medicine related issues

(Note: PrescQIPP login required)

Please click here for PSNC summary of updates and guidance relating to community pharmacy and Covid-19

Analgesia

NSAIDs

Please click here for NHS advice on the use of ibuprofen during the COVID-19 outbreak. 

Please click here for CAS alert for the NHSE message for all staff regarding use of ibuprofen during the COVID-19 outbreak. 

Paracetamol

Please click here for Royal Pharmaceutical Society Advice to pharmacists regarding "packing down" of paracetamol during COVID-19 outbreak. 

 

 

Multiple Sclerosis

Please click here for the Association of British Neurologists (ABN) guidance on the use of Disease Modifying Therapies (DMARDs) during the COVID-19 outbreak.

Cardiology

 

ACEi/ARBs

Please click here for the MHRA alert regarding high blood pressure medication during the COVID-19 outbreak.

Please click here for the British Cardiovascular Society and British Society for Heart Failure's joint statement on use of ACEi and ARBs during the COVID-19 outbreak.

Please click here for the European Society of Cardiology's guidance on ACEi and ARBs during the COVID-19 outbreak.

Anticoagulation

Please click here for the NHSE advice regarding anticoagulation during the COVID-19 outbreak

Inflammatory Bowel Disease

Please click here for advice from International Organization for the study of Inflammatory Bowel Disease during the COVID-19 outbreak.

Please click here for advice from British Society of Gastroenterology on use of immunosuppression during the COVID-19 outbreak.

Please click here for patient advice from Crohn's and Colitis UK during the COVID-19 outbreak.

Renal disease

Please click here for patient advice from Kidney Care UK during the COVID-19 outbreak.

Dermatology

Please click here for statement from International Psoriasis Council on immunosuppresant medications during the COVID-19 outbreak.

Please click here for a Safe Prescribing and Monitoring Protocol for Systemic immunomodulatory therapies for immune-mediated inflammatory skin disease in the context of Coronavirus (COVID-19).

 

Rheumatology

Please click here for statement from British Society of Rheumatology on immunosuppresant medications during the COVID-19 outbreak.

Please click here for guidance from British Society of Rheumatology on identifying high risk patients on immunosuppression during the COVID-19 outbreak. 

Contraception

Please click here for specific advice from Faculty of Sexual and Reproductive Health (FSRH) regarding provision of effective contraception during the COVID-19 outbreak.

Respiratory

Please click here for information, guidance and resources from the British Thoracic Society (BTS) to support the respiratory community during the COVID-19 pandemic

 

Diabetes

Please click here for Primary Care Diabetes Society guidance on managing diabetes during the COVID-19 outbreak. 

Care Homes

 

 Please click here for the good practice guide from the British Geriatrics Society (BGS) on Managing the COVID-19 pandemic in care homes.

Systemic Anti-cancer treatments

Please click here for NICE rapid guideline on delivery of systemic anticancer treatments during COVID-19 outbreak.